Tulane Home Tulane Shield logo linking to site home page

tracking code

World Hypertension League honors Dr. Jiang He

July 14, 2022 10:45 AM
 | 
Lance Sumler lsumler@tulane.edu

Jiang He
Dr. Jiang He is the Joseph S. Copes Chair of Epidemiology and Director of the Translational Science institute at Tulane University School of Public Health and Tropical Medicine. (Photo by Paula Burch-Celentano)

The World Hypertension League has honored Tulane researcher Dr. Jiang He, Joseph S. Copes Chair of Epidemiology and Director of the Translational Science Institute at Tulane University School of Public Health and Tropical Medicine, for his impact in the field of hypertension research.

The global organization, which consists of more than 80 national hypertension societies, recently selected He as a WHL 2022 Excellence Award Winner for his contributions to global hypertension prevention and control.

“Elevated blood pressure is the largest single contributing risk factor to global morbidity and mortality, which is why I am so passionate about doing research in this field,” He said. “I am honored that the World Hypertension League chose to honor me for the work I’ve done, and I am looking forward to ongoing research that will contribute to effective prevention and treatments of hypertension to help people to live healthier and longer.”

In 2017, the World Hypertension League created the WHL Detlev Gant Excellence Award in Hypertension and Global Health Implementation to honor former WHL President Prof. Detlev Ganten, MD, PhD (1990-1995 WHL President) for his career in the prevention and treatment of high blood pressure, the pathophysiology and molecular biology of high blood pressure, pharmacology of antihypertensive drugs, and hormonal regulation of blood pressure, especially the renin‐angiotensin system. 

He, an internationally respected expert in the clinical, translational and epidemiological research of cardiovascular and kidney diseases, has conducted novel studies in obesity, hypertension, diabetes, stroke, cardiovascular disease, and chronic kidney disease funded by the National Institutes of Health. He has served as the principal investigator and co-investigator for more than 40 major NIH research awards totaling more than $175 million.